Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.

アブストラクト
ジャーナル名	The journal of allergy and clinical immunology. In practice
投稿日	2021/5/26
投稿者	Bluestein, Sara Beth; Yu, Roger; Stone, Cosby Jr; Phillips, Elizabeth J
組織名	Division of Allergy, Pulmonary, and Critical Care Medicine, Department of;Medicine, Vanderbilt University Medical Center, Nashville, Tenn.;Division of Infectious Diseases, Department of Medicine, Vanderbilt University;Medical Center, Nashville, Tenn; Pritzker School of Medicine, University of;Chicago, Chicago, Ill.;Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Division of;Infectious Diseases, Department of Medicine, Vanderbilt University Medical;Center, Nashville, Tenn; Institute of Immunology and Infectious Diseases, Murdoch;University, Murdoch, Australia. Electronic address:;elizabeth.j.phillips@vanderbilt.edu.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/34033979/